Skip to main content

Loss expected for Aptevo Therapeutics

Analysts expect Aptevo Therapeutics Inc. (Nasdaq: APVO) to fall to a loss for the current quarter. The stock price tumbled $1.25 to close at $3.14.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.